Evidence map›Paper›PMID 31350464›Full record

ArticleScientific reports2019

Differential neurodegenerative phenotypes are associated with heterogeneous voiding dysfunction in a coronavirus-induced model of multiple sclerosis.

Sanghee Lee, Balachandar Nedumaran, Joseph Hypolite, Brian Caldwell, Michael C Rudolph, Anna P Malykhina

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. PART 2: Mouse models for multiple sclerosis research.Neurourology and urodynamics · 2021
    Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Sanghee LeeDepartment of Urology, University of California San Diego, La Jolla, California, USA.
Balachandar NedumaranDivision of Urology, Department of Surgery, University of Colorado Denver, Aurora, Co, USA.
Joseph HypoliteDivision of Urology, Department of Surgery, University of Colorado Denver, Aurora, Co, USA.
Brian CaldwellDivision of Urology, Department of Surgery, University of Colorado Denver, Aurora, Co, USA.
Michael C RudolphDivision of Endocrinology, Metabolism & Diabetes, University of Colorado Denver, Aurora, Co, USA.ORCID http://orcid.org/0000-0002-6147-212X
Anna P MalykhinaDivision of Urology, Department of Surgery, University of Colorado Denver, Aurora, Co, USA. Anna.Malykhina@ucdenver.edu.
University of Colorado Denver · USUniversity of California San Diego · USUniversity of Colorado Anschutz Medical Campus · US

Funding

Mechanisms of neurogenic bladder dysfunction in a viral murine model of multiple sclerosisR01DK116648 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI MALYKHINA, ANNA P · 2020 to 2022
$1.0M
Neurogenic bladder dysfunctions in neurological disorders P20DK097819 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI MALYKHINA, ANNA P · 2012 to 2013
$842k
NIDDK NIH HHS P20 DK097819NIDDK NIH HHS R01 DK116648
6 · The paper itself

Abstract

Patients with multiple sclerosis (MS) develop a variety of lower urinary tract symptoms (LUTS). We previously characterized a murine model of neurogenic bladder dysfunction induced by a neurotropic strain of a coronavirus. In the present study, we further study the role of long-lasting neurodegeneration on the development of neurogenic bladder dysfunction in mice with corona-virus induced encephalitis (CIE). Long-term follow up study revealed three phenotypes of neurodegenerative symptom development: recovery (REC group), chronic progression (C-PRO group) and chronic disease with relapsing-remitting episodes (C-RELAP group). The levels of IL-1β in REC group, IL-10 in C-RELAP group, and IL-1β, IL-6, IL-10 and TNF-α in C-PRO group were diminished in the brain. The levels of TNF-α in REC group and INF-γ, IL-2, TGF-β and TNF-α in the C-PRO group were also diminished in the urinary bladder. Mice in C-RELAP group showed a delayed recovery of voiding function. In vitro contractility studies determined a decreased basal detrusor tone and reduced amplitude of nerve-mediated contractions in C-RELAP group, whereas C-PRO group had elevated muscle-mediated contractions. In conclusion, mice with CIE developed three phenotypes of neurologic impairment mimicking different types of MS progression in humans and showed differential mechanisms driving neurogenic bladder dysfunction.

Indexed as

Murine hepatitis virusPhenotypeAnimalsCoronavirus InfectionsCytokinesEncephalomyelitis, Autoimmune, ExperimentalEnzyme-Linked Immunosorbent AssayFollow-Up StudiesIntercellular Signaling Peptides and ProteinsLower Urinary Tract SymptomsMaleMiceMice, Inbred C57BLMultiple SclerosisUrinary Bladder, NeurogenicCytokinesIntercellular Signaling Peptides and Proteins

Identifiers

PMID31350464
PMCPMC6659655
OpenAlexW2966659406

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.